Table 3.
Chr. | CpG | bp | CpG island | Gene | Gene location | Meta p | Meta Z |
---|---|---|---|---|---|---|---|
4 | cg22982173 | 3,076,557 | Island | HTT | First exon | 6.5 × 10−26 | 10.53 |
17 | cg26892702 | 7,132,489 | DVL2 | Body | 5.3 × 10−10 | −6.21 | |
3 | cg23819669 | 128,187,274 | DNAJB8 | TSS1500 | 4.2 × 10−9 | −5.88 | |
2 | cg19759282 | 175,351,649 | Island | GPR155 | 5′-UTR; 1st exon | 4.4 × 10−9 | 5.87 |
13 | cg16739503 | 114,862,324 | S_Shore | RASA3 | Body | 6.5 × 10−9 | −5.8 |
10 | cg20684718 | 13,248,241 | MCM10 | Body | 1.4 × 10−8 | −5.68 | |
12 | cg04605980 | 117,471,700 | 1.8 × 10−8 | −5.63 | |||
11 | cg06993329 | 886,695 | N_Shore | CHID1 | Body | 1.9 × 10−8 | −5.63 |
17 | cg04683330 | 80,041,239 | Island | FASN | Body | 1.9 × 10−8 | −5.62 |
12 | cg16320626 | 121,877,851 | N_Shelf | KDM2B | Body | 2.1 × 10−8 | −5.6 |
3 | ch.3.753362Ra | 37,048,044 | MLH1 | 5′-UTR; body | 2.4 × 10−8 | 5.58 | |
16 | cg09080920 | 928,338 | Island | LMF1 | Body | 2.5 × 10−8 | −5.57 |
22 | cg14703589 | 31,644,558 | LIMK2 | First exon; 5′-UTR; body | 2.6 × 10−8 | −5.57 | |
12 | cg17859634 | 124,798,815 | Island | FAM101A | Body | 3.4 × 10−8 | −5.52 |
14 | cg04285477 | 74,194,516 | C14orf43 | Body | 3.6 × 10−8 | −5.51 | |
17 | cg23148992 | 3,558,246 | CTNS | Body | 4.1 × 10−8 | −5.49 | |
19 | cg08117431 | 5,455,497 | Island | ZNRF4 | 5′-UTR; 1st exon | 4.2 × 10−−8 | −5.48 |
2 | cg15115604 | 241,069,379 | Island | MYEOV2 | Body | 5.0 × 10−8 | −5.45 |
14 | cg10929299 | 50,334,860 | 5.1 × 10−8 | 5.45 | |||
19 | cg10585870 | 14,530,314 | Island | DDX39 | TSS200 | 5.6 × 10−8 | 5.43 |
11 | cg15746396 | 13,485,203 | Island | BTBD10 | TSS1500 | 6.2 × 10−8 | 5.41 |
7 | cg14640310 | 44,058,913 | Island | POLR2J4 | TSS200 | 6.9 × 10−8 | 5.39 |
2 | cg22296756 | 240,305,369 | HDAC4 | 5′-UTR | 6.9 × 10−8 | −5.39 | |
19 | cg11543665 | 8,373,294 | Island | CD320 | TSS201 | 6.9 × 10−8 | 5.39 |
2 | cg05054944 | 25,856,333 | DTNB | Body | 7.2 × 10−8 | −5.39 | |
16 | cg00284420 | 87,311,948 | 7.5 × 10−8 | −5.38 | |||
17 | cg24965497 | 7,227,181 | N_Shore | NEURL4 | Body | 7.6 × 10−8 | −5.38 |
4 | cg13731523 | 3,047,190 | S_Shelf | 8.0 × 10−8 | −5.37 | ||
17 | cg14517001 | 80,179,931 | Island | 8.2 × 10−8 | −5.36 | ||
19 | cg20635595 | 48,281,627 | Island | SEPW1 | TSS1500 | 8.4 × 10−8 | 5.36 |
11 | cg16356630 | 14,683,035 | PDE3B | Body | 8.7 × 10−8 | −5.35 | |
4 | cg01200289 | 77,227,751 | Island | STBD1 | First exon; 5′-UTR | 9.0 × 10−8 | 5.35 |
12 | cg11881599 | 92,814,084 | CLLU1OS | 3′-UTR; TSS1500 | 9.2 × 10−8 | 5.34 |
The table reports 33 genome-wide significant CpGs (meta-analysis p value <10−7). A positive (negative) value of the meta-analysis Z statistic indicates that the CpG is hypermethylated (hypomethylated) in human HDGECs. In this case–control study, we did not distinguish pre-manifest from manifest HD. The Z statistic is based on Stouffer’s meta-analysis method across the aggregated Enroll-HD samples and the Registry-HD data. Columns report the chromosome, CpG, position (hg19 assembly), the relative location to the nearest CpG island, nearest gene, location of the CpG with respect to the gene, meta-analysis (unadjusted, two-sided) p value, and Z statistic.
aThe unusual probe name “ch.3.753362R” reflects a CpH probe (CA, CC, CT) as opposed to a CpG probe, which targets the reverse strand on chromosome 3 (hg19 coordinate 753362).